Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat

Sang M. Lee, Tae Y. Yune, Sun J. Kim, Do W. Park, Young K. Lee, Young C. Kim, Young Jun Oh, George J. Markelonis, Tae H. Oh

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

We examined the effects of minocycline, an anti-inflammatory drug, on functional recovery following spinal cord injury (SCI). Rats received a mild, weight-drop contusion injury to the spinal cord and were treated with the vehicle or minocycline at a dose of 90 mg/kg immediately after SCI and then twice at a dose of 45 mg/kg every 12 h. Injecting minocycline after SCI improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Twenty four to 38 days after SCI, BBB scores were significantly higher in minocycline-treated rats as compared with those in vehicle-treated rats. Morphological analysis showed that lesion size increased progressively in both vehicle-treated and minocycline-treated spinal cords. However, in response to treatment with minocycline, the lesion size was significantly reduced at 21-38 days after SCI when compared to the vehicle control. Minocycline treatment significantly reduced the number of terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive cells 24 h after SCI as compared to that of the vehicle control. DNA gel electrophoresis also revealed a marked decrease in DNA laddering in response to treatment with minocycline. In addition, minocycline treatment significantly reduced the specific caspase-3 activity after SCI as compared to that of vehicle control. Furthermore, RT-PCR analyses revealed that minocycline treatment increased expression of interleukin-10 mRNA but decreased tumor necrosis factor-α expression. These data suggest that, after SCI, minocycline treatment modulated expression of cytokines, attenuated cell death and the size of lesions, and improved functional recovery in the injured rat. This approach may provide a therapeutic intervention enabling us to reduce cell death and improve functional recovery after SCI.

Original languageEnglish
Pages (from-to)1017-1027
Number of pages11
JournalJournal of Neurotrauma
Volume20
Issue number10
DOIs
Publication statusPublished - 2003 Jan 1

Fingerprint

Minocycline
Spinal Cord Injuries
Cell Death
DNA Nucleotidylexotransferase
Contusions
DNA
In Situ Nick-End Labeling
Biotin
Cell Size
Caspase 3
Interleukin-10
Electrophoresis
Spinal Cord
Anti-Inflammatory Agents
Extremities
Tumor Necrosis Factor-alpha
Gels
Cytokines

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Lee, S. M., Yune, T. Y., Kim, S. J., Park, D. W., Lee, Y. K., Kim, Y. C., ... Oh, T. H. (2003). Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat. Journal of Neurotrauma, 20(10), 1017-1027. https://doi.org/10.1089/089771503770195867
Lee, Sang M. ; Yune, Tae Y. ; Kim, Sun J. ; Park, Do W. ; Lee, Young K. ; Kim, Young C. ; Oh, Young Jun ; Markelonis, George J. ; Oh, Tae H. / Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat. In: Journal of Neurotrauma. 2003 ; Vol. 20, No. 10. pp. 1017-1027.
@article{55afc8f513fb450cbccf217a2b0cf818,
title = "Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat",
abstract = "We examined the effects of minocycline, an anti-inflammatory drug, on functional recovery following spinal cord injury (SCI). Rats received a mild, weight-drop contusion injury to the spinal cord and were treated with the vehicle or minocycline at a dose of 90 mg/kg immediately after SCI and then twice at a dose of 45 mg/kg every 12 h. Injecting minocycline after SCI improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Twenty four to 38 days after SCI, BBB scores were significantly higher in minocycline-treated rats as compared with those in vehicle-treated rats. Morphological analysis showed that lesion size increased progressively in both vehicle-treated and minocycline-treated spinal cords. However, in response to treatment with minocycline, the lesion size was significantly reduced at 21-38 days after SCI when compared to the vehicle control. Minocycline treatment significantly reduced the number of terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive cells 24 h after SCI as compared to that of the vehicle control. DNA gel electrophoresis also revealed a marked decrease in DNA laddering in response to treatment with minocycline. In addition, minocycline treatment significantly reduced the specific caspase-3 activity after SCI as compared to that of vehicle control. Furthermore, RT-PCR analyses revealed that minocycline treatment increased expression of interleukin-10 mRNA but decreased tumor necrosis factor-α expression. These data suggest that, after SCI, minocycline treatment modulated expression of cytokines, attenuated cell death and the size of lesions, and improved functional recovery in the injured rat. This approach may provide a therapeutic intervention enabling us to reduce cell death and improve functional recovery after SCI.",
author = "Lee, {Sang M.} and Yune, {Tae Y.} and Kim, {Sun J.} and Park, {Do W.} and Lee, {Young K.} and Kim, {Young C.} and Oh, {Young Jun} and Markelonis, {George J.} and Oh, {Tae H.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1089/089771503770195867",
language = "English",
volume = "20",
pages = "1017--1027",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

Lee, SM, Yune, TY, Kim, SJ, Park, DW, Lee, YK, Kim, YC, Oh, YJ, Markelonis, GJ & Oh, TH 2003, 'Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat', Journal of Neurotrauma, vol. 20, no. 10, pp. 1017-1027. https://doi.org/10.1089/089771503770195867

Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat. / Lee, Sang M.; Yune, Tae Y.; Kim, Sun J.; Park, Do W.; Lee, Young K.; Kim, Young C.; Oh, Young Jun; Markelonis, George J.; Oh, Tae H.

In: Journal of Neurotrauma, Vol. 20, No. 10, 01.01.2003, p. 1017-1027.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat

AU - Lee, Sang M.

AU - Yune, Tae Y.

AU - Kim, Sun J.

AU - Park, Do W.

AU - Lee, Young K.

AU - Kim, Young C.

AU - Oh, Young Jun

AU - Markelonis, George J.

AU - Oh, Tae H.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We examined the effects of minocycline, an anti-inflammatory drug, on functional recovery following spinal cord injury (SCI). Rats received a mild, weight-drop contusion injury to the spinal cord and were treated with the vehicle or minocycline at a dose of 90 mg/kg immediately after SCI and then twice at a dose of 45 mg/kg every 12 h. Injecting minocycline after SCI improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Twenty four to 38 days after SCI, BBB scores were significantly higher in minocycline-treated rats as compared with those in vehicle-treated rats. Morphological analysis showed that lesion size increased progressively in both vehicle-treated and minocycline-treated spinal cords. However, in response to treatment with minocycline, the lesion size was significantly reduced at 21-38 days after SCI when compared to the vehicle control. Minocycline treatment significantly reduced the number of terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive cells 24 h after SCI as compared to that of the vehicle control. DNA gel electrophoresis also revealed a marked decrease in DNA laddering in response to treatment with minocycline. In addition, minocycline treatment significantly reduced the specific caspase-3 activity after SCI as compared to that of vehicle control. Furthermore, RT-PCR analyses revealed that minocycline treatment increased expression of interleukin-10 mRNA but decreased tumor necrosis factor-α expression. These data suggest that, after SCI, minocycline treatment modulated expression of cytokines, attenuated cell death and the size of lesions, and improved functional recovery in the injured rat. This approach may provide a therapeutic intervention enabling us to reduce cell death and improve functional recovery after SCI.

AB - We examined the effects of minocycline, an anti-inflammatory drug, on functional recovery following spinal cord injury (SCI). Rats received a mild, weight-drop contusion injury to the spinal cord and were treated with the vehicle or minocycline at a dose of 90 mg/kg immediately after SCI and then twice at a dose of 45 mg/kg every 12 h. Injecting minocycline after SCI improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Twenty four to 38 days after SCI, BBB scores were significantly higher in minocycline-treated rats as compared with those in vehicle-treated rats. Morphological analysis showed that lesion size increased progressively in both vehicle-treated and minocycline-treated spinal cords. However, in response to treatment with minocycline, the lesion size was significantly reduced at 21-38 days after SCI when compared to the vehicle control. Minocycline treatment significantly reduced the number of terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive cells 24 h after SCI as compared to that of the vehicle control. DNA gel electrophoresis also revealed a marked decrease in DNA laddering in response to treatment with minocycline. In addition, minocycline treatment significantly reduced the specific caspase-3 activity after SCI as compared to that of vehicle control. Furthermore, RT-PCR analyses revealed that minocycline treatment increased expression of interleukin-10 mRNA but decreased tumor necrosis factor-α expression. These data suggest that, after SCI, minocycline treatment modulated expression of cytokines, attenuated cell death and the size of lesions, and improved functional recovery in the injured rat. This approach may provide a therapeutic intervention enabling us to reduce cell death and improve functional recovery after SCI.

UR - http://www.scopus.com/inward/record.url?scp=0142025464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142025464&partnerID=8YFLogxK

U2 - 10.1089/089771503770195867

DO - 10.1089/089771503770195867

M3 - Article

VL - 20

SP - 1017

EP - 1027

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 10

ER -